Scientists have discovered that a potential new drug can reverse severe fatty liver disease in animal models by restoring gut ...
BioSpectrum India on MSN
Fatty liver disease management: antifibrotic treatment, disease staging and transplant eligibility
Fatty liver disease is common, but it needs timely attention when inflammation and scarring begin. Non-Alcoholic ...
A new Houston Methodist Research Institute study finds that older adults with metabolic dysfunction-associated steatotic liver disease (MASLD) who received GLP-1-based treatment experienced ...
A new update from the American Gastroenterological Association (AGA) urges stronger prevention efforts and better early-detection tools for hepatocellular carcinoma (HCC), the leading cause of ...
Health and Me on MSN
Fatty liver disease: Scientists identify 5 subtypes with different health risks
Researchers also identified associations between specific subtypes and conditions such as depression, sleep apnea and ...
NORTH CHICAGO, Ill., Nov. 13, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new data for its pan ...
Cryptogenic cirrhosis is liver scarring that occurs without a known cause. It can cause fatigue, appetite loss, weight loss, swelling, and jaundice and may lead to irreversible liver damage. The liver ...
SYDNEY--Australia's CSL said on Monday it has entered into an exclusive agreement with Alentis Therapeutics to jointly develop and promote a rare kidney and liver disease treatment.
A case report and literature review describes a cirrhotic patient with L1/2 spondylitis caused by both Lactococcus lactis and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results